TW200732337A - Organic compounds - Google Patents

Organic compounds

Info

Publication number: TW200732337A
Authority: TW; Taiwan
Prior art keywords: organic compounds; pharmaceuticals; preparing; formula; free
Prior art date: 2005-12-09

Application number

TW095146173A

Other languages

English (en)

Inventor

David Andrew Sandham

Catherine Leblanc

Harinder Pal Singh

Lyndon Nigel Brown

Original Assignee

Novartis Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-09

Filing date

2006-12-08

Publication date

2007-09-01

2006-12-08 Application filed by Novartis Ag filed Critical Novartis Ag

2007-09-01 Publication of TW200732337A publication Critical patent/TW200732337A/zh

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

TW095146173A 2005-12-09 2006-12-08 Organic compounds TW200732337A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0525144.2A GB0525144D0 (en)	2005-12-09	2005-12-09	Organic compounds

Publications (1)

Publication Number	Publication Date
TW200732337A true TW200732337A (en)	2007-09-01

Family

ID=35735863

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW095146173A TW200732337A (en)	2005-12-09	2006-12-08	Organic compounds

Country Status (17)

Country	Link
US (1)	US20080312229A1 (zh)
EP (1)	EP1960398B1 (zh)
JP (1)	JP2009518343A (zh)
KR (1)	KR20080065699A (zh)
CN (1)	CN101326185A (zh)
AR (1)	AR056887A1 (zh)
AT (1)	ATE482957T1 (zh)
AU (1)	AU2006322206B2 (zh)
BR (1)	BRPI0619529A2 (zh)
CA (1)	CA2630611A1 (zh)
DE (1)	DE602006017256D1 (zh)
GB (1)	GB0525144D0 (zh)
PE (1)	PE20071035A1 (zh)
PT (1)	PT1960398E (zh)
RU (1)	RU2008127439A (zh)
TW (1)	TW200732337A (zh)
WO (1)	WO2007065683A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MY144903A (en)	2004-06-17	2011-11-30	Novartis Ag	Pyrrolopyridine derivatives and their use as crth2 antagonists
GB0525143D0 (en) *	2005-12-09	2006-01-18	Novartis Ag	Organic compounds
PL2051962T3 (pl)	2006-08-07	2012-03-30	Actelion Pharmaceuticals Ltd	Pochodne kwasu (3-amino-1,2,3,4-tetrahydro-9h-karbazol-9-ilo)-octowego
US8563573B2 (en)	2007-11-02	2013-10-22	Vertex Pharmaceuticals Incorporated	Azaindole derivatives as CFTR modulators
WO2009093029A1 (en) *	2008-01-22	2009-07-30	Oxagen Limited	Compounds having crth2 antagonist activity
JP5658284B2 (ja) *	2010-01-27	2015-01-21	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｃｒｔｈ２アンタゴニストとしてのピラゾール化合物
CN102791689B (zh)	2010-03-22	2014-10-29	埃科特莱茵药品有限公司	3-（杂芳基-氨基）-1,2,3,4-四氢-9h-咔唑衍生物及其作为***素d2受体调节剂的用途
US8802868B2 (en)	2010-03-25	2014-08-12	Vertex Pharmaceuticals Incorporated	Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
KR20130056244A (ko)	2010-04-22	2013-05-29	버텍스 파마슈티칼스 인코포레이티드	시클로알킬카르복스아미도-인돌 화합물의 제조 방법
EP2457900A1 (en)	2010-11-25	2012-05-30	Almirall, S.A.	New pyrazole derivatives having CRTh2 antagonistic behaviour
KR101928595B1 (ko)	2011-04-14	2018-12-12	이도르시아 파마슈티컬스 리미티드	7-(헤테로아릴-아미노)-6,7,8,9-테트라히드로피리도［1,2-ａ］인돌 아세트산 유도체 및 프로스타글란딘 ｄ2 수용체 조절자로서의 이의 용도
US9233098B2 (en) *	2011-11-17	2016-01-12	Kbp Biosciences Co., Ltd.	Nitrogen-containing fused ring compounds as CRTH2 antagonists
HUE039614T2 (hu)	2014-03-17	2019-01-28	Idorsia Pharmaceuticals Ltd	Azaindol-ecetsav-származékok és prosztaglandin D2 receptor modulátorokként történõ alkalmazásuk
ES2699379T3 (es)	2014-03-18	2019-02-11	Idorsia Pharmaceuticals Ltd	Derivados de ácido azaindol acético y su uso como moduladores del receptor de prostaglandina D2
PL3925607T3 (pl)	2014-04-15	2023-10-30	Vertex Pharmaceuticals Incorporated	Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa
ES2867757T3 (es)	2015-09-15	2021-10-20	Idorsia Pharmaceuticals Ltd	Formas cristalinas
JP2021502345A (ja)	2017-11-06	2021-01-28	ラプト・セラピューティクス・インコーポレイテッド	抗がん剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3320268A (en) *	1964-08-14	1967-05-16	Merck & Co Inc	1-aroyl or heteroaroyl-7-azaindole-3-carboxylates and derivatives
PT1590314E (pt) *	2003-02-06	2015-11-19	Dompã Farmaceutici S P A	Ácidos 2-aril-acéticos, seus derivados e composições farmacêuticas que os contêm
MY144903A (en) *	2004-06-17	2011-11-30	Novartis Ag	Pyrrolopyridine derivatives and their use as crth2 antagonists

2005
- 2005-12-09 GB GBGB0525144.2A patent/GB0525144D0/en not_active Ceased
2006
- 2006-12-06 PE PE2006001570A patent/PE20071035A1/es not_active Application Discontinuation
- 2006-12-07 RU RU2008127439/04A patent/RU2008127439A/ru unknown
- 2006-12-07 CN CNA2006800462767A patent/CN101326185A/zh active Pending
- 2006-12-07 AU AU2006322206A patent/AU2006322206B2/en not_active Ceased
- 2006-12-07 US US12/096,453 patent/US20080312229A1/en not_active Abandoned
- 2006-12-07 KR KR1020087013721A patent/KR20080065699A/ko active IP Right Grant
- 2006-12-07 AR ARP060105412A patent/AR056887A1/es unknown
- 2006-12-07 AT AT06819000T patent/ATE482957T1/de not_active IP Right Cessation
- 2006-12-07 JP JP2008543732A patent/JP2009518343A/ja active Pending
- 2006-12-07 DE DE602006017256T patent/DE602006017256D1/de active Active
- 2006-12-07 CA CA002630611A patent/CA2630611A1/en not_active Abandoned
- 2006-12-07 WO PCT/EP2006/011770 patent/WO2007065683A1/en active Application Filing
- 2006-12-07 EP EP06819000A patent/EP1960398B1/en not_active Not-in-force
- 2006-12-07 PT PT06819000T patent/PT1960398E/pt unknown
- 2006-12-07 BR BRPI0619529-6A patent/BRPI0619529A2/pt not_active IP Right Cessation
- 2006-12-08 TW TW095146173A patent/TW200732337A/zh unknown

Also Published As

Publication number	Publication date
ATE482957T1 (de)	2010-10-15
EP1960398A1 (en)	2008-08-27
GB0525144D0 (en)	2006-01-18
US20080312229A1 (en)	2008-12-18
PE20071035A1 (es)	2007-10-30
KR20080065699A (ko)	2008-07-14
CA2630611A1 (en)	2007-06-14
RU2008127439A (ru)	2010-01-20
PT1960398E (pt)	2010-11-26
DE602006017256D1 (de)	2010-11-11
AU2006322206A1 (en)	2007-06-14
EP1960398B1 (en)	2010-09-29
JP2009518343A (ja)	2009-05-07
AR056887A1 (es)	2007-10-31
AU2006322206B2 (en)	2010-08-19
BRPI0619529A2 (pt)	2011-10-04
WO2007065683A1 (en)	2007-06-14
CN101326185A (zh)	2008-12-17

Publication	Publication Date	Title
TW200732335A (en)	2007-09-01	Organic compounds
TW200732337A (en)	2007-09-01	Organic compounds
TW200617009A (en)	2006-06-01	Organic compounds
TW200635921A (en)	2006-10-16	Organic compounds
GB0508318D0 (en)	2005-06-01	Organic compounds
GB0508314D0 (en)	2005-06-01	Organic compounds
JO2734B1 (en)	2013-09-15	Organic compounds
WO2007065684A3 (en)	2007-08-02	Bicyclic heteroyclic compounds as antiinflammatory or antiallergic agents
SG169989A1 (en)	2011-04-29	Aryloazol-2-yl cyanoethylamino compounds, method of making and method of using thereof
TW200800999A (en)	2008-01-01	Novel compounds
DE602005014473D1 (en)	2009-06-25	Amino-propanolderivate
TW200638930A (en)	2006-11-16	Acetylene derivatives
TW200637837A (en)	2006-11-01	Fungicides
TW200745084A (en)	2007-12-16	Novel compounds
ES2368594T3 (es)	2011-11-18	Derivados sustituidos de ciclohexilmetilo.
MX2009007713A (es)	2009-07-29	Derivados de piridazina, procedimientos para su preparacion y su uso como fungicidas.
MY140739A (en)	2010-01-15	2, 6-quinolinyl derivatives, processes for preparing them and their uses
BRPI0519292A2 (pt)	2009-01-06	compostos orgÂnicos
TW200505920A (en)	2005-02-16	Organic compounds
TW200800967A (en)	2008-01-01	Benzimidazole thiophene compounds
DE602004024213D1 (en)	2009-12-31	Aminopropanolderivate
SE0401762D0 (sv)	2004-07-05	Novel compounds
DE602006019732D1 (de)	2011-03-03	Indolylmaleimidderivate
GB0412769D0 (en)	2004-07-07	Organic compounds
TW200508197A (en)	2005-03-01	Indolone-acetamide derivatives, processes for preparing them and their uses